Table 2. Chromosomal aberrations of EMZL at different extranodal sites.
| Location | Chromosomal alteration | Frequency (%) |
|---|---|---|
| Ocular adnexa | t(11;18)(q21;q21) | 10 |
| t(14;18)(q32;q21) | 19 | |
| t(3;14)(p14.1;q32) | 14 | |
| A20 inactivation (6q23 deletion) | 20 | |
| Trisomy 3, 18 | ? | |
| 5q (ODZ2) and 9p (JMJD2C) | ? | |
| Stomach | t(11;18)(q21;q21) | 22–24 |
| t(1;14)(p22;q32) | 3 | |
| Trisomy 3, 7, 12, 18 | ||
| Skin | t(14;18)(q32;q21) | 14 |
| t(3;14)(p14.1;q32 | 10 | |
| Trisomy 3, 18 | ||
| 5q (ODZ2) | ||
| Intestine | t(11;18)(q21;q21) | 13 |
| t(1;14)(p22;q32) | 10 | |
| Trisomy 3, 12, 18 | ||
| Lung | t(14;18)(q32;q21) | 38–53 |
| t(1;14)(p22;q32) | 11 | |
| Trisomy 3, 12, 18 | 7 | |
| Salivary gland | t(11;18)(q21;q21) | 1 |
| t(14;18)(q32;q21) | 5 | |
| A20 inactivation | ? | |
| Trisomy 3, 7, 18 | ||
| Thyroid gland | t(3;14)(p14.1;q32) | 50 |
| A20 inactivation | ? | |
| Trisomy 3, 12 | ||
| Breast | Trisomy 3, 18 | Rare |